SCHEMBL730717

SCHEMBL730717

CCCNN1CCNCC1

nearest known ligand 0.68

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 4/20 0.68
GNAO1 P09471 4/20 0.68
GNAI1 P63096 4/20 0.68
HRH4 Q9H3N8 1/20 0.34
HSD17B10 Q99714 1/20 0.31
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL27689010 0.98 GNAI3 (0.66) GNAI3GNAO1GNAI1HRH4HSD17B10
SCHEMBL4974361 0.86 GNAO1 (0.81) GNAI3GNAO1GNAI1HRH4SIGMAR1
SCHEMBL4723776 0.86
SCHEMBL3260063 0.85 GNAO1 (0.92) GNAI3GNAO1GNAI1HRH4SIGMAR1
SCHEMBL27389928 0.83 GNAO1 (0.96) GNAI3GNAO1GNAI1HRH4
SCHEMBL20000752 0.82
SCHEMBL8778709 0.82 GNAI3 (0.45) GNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL5370724 0.81 GNAO1 (1.00) GNAI3GNAO1GNAI1HRH4
Bromide SCHEMBL27708672 0.81 GNAO1 (0.93) GNAI3GNAO1GNAI1HRH4
SCHEMBL10890174 0.80 GNAI3 (0.56) GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108530453-A One kind 2(3)To methylthio phenyl vinyl-benzofuran quinoline and its preparation method and application 中山大学 2018-09-14 CN claimed
CN-102472984-A Composition for stripping copper or copper alloy photoresist DONGWOO FINE CHEM CO LTD 2012-05-23 CN claimed
US-5071951-A EPOXY HARDENING AGENTS RUTGERSWERKE AG (DE) 1991-12-10 US claimed
EP-0402582-A2 Curing agent for epoxy resins RÜTGERSWERKE AKTIENGESELLSCHAFT (DE) 1990-12-19 EP claimed
US-4889672-A MIXING WITH ADDUCT OF EPOXIDIZED POLYBUTADIENE AND AMINE ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1989-12-26 US claimed
EP-3679179-B1 COMPOSITION FOR METAL ELECTROPLATING COMPRISING LEVELING AGENT BASF SE (DE) 2023-10-11 EP disclosed
CN-111051576-B Composition for metal plating comprising leveling agent 巴斯夫欧洲公司 2022-08-16 CN disclosed
US-11387108-B2 Composition for metal electroplating comprising leveling agent BASF SE (DE) 2022-07-12 US disclosed
EP-3679179-A1 COMPOSITION FOR METAL ELECTROPLATING COMPRISING LEVELING AGENT BASF SE (DE) 2020-07-15 EP disclosed
US-20200185224-A1 COMPOSITION FOR METAL ELECTROPLATING COMPRISING LEVELING AGENT BASF SE (DE) 2020-06-11 US disclosed
CN-111051576-A Composition for metal plating comprising leveling agent 巴斯夫欧洲公司 2020-04-21 CN disclosed
WO-2019043146-A1 COMPOSITION FOR METAL ELECTROPLATING COMPRISING LEVELING AGENT BASF SE (DE) 2019-03-07 WO disclosed
US-20080281044-A1 Endosomolytic Modified Poly(Alcohol) and Poly(Amine) Polymers ROCHE MADISON INC. 2008-11-13 US disclosed
US-20080269450-A1 Endosomolytic Poly-Beta-Aminoester Polymers ROCHE MADISON INC. 2008-10-30 US disclosed
US-20080152661-A1 Polyconjugates for In Vivo Delivery of Polynucleotides Arrowhead Pharmaceuticals, Inc. 2008-06-26 US disclosed
WO-2008022309-A2 POLYCONJUGATES FOR IN VIVO DELIVERY OF POLYNUCLEOTIDES F. HOFFMANN-LA ROCHE AG (US) 2008-02-21 WO disclosed
US-5858467-A MILLING OF ADDITIVES IN THE POWDER STATE DIRECTLY INTO LATEX OF FLUOROELASTOMER AUSIMONT S. P. A. (IT) 1999-01-12 US disclosed
EP-0278404-B1 PROCESS FOR PRODUCING CERAMIC MOLDING ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1992-08-12 EP disclosed
US-4889672-A MIXING WITH ADDUCT OF EPOXIDIZED POLYBUTADIENE AND AMINE ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1989-12-26 US disclosed
EP-0278404-A2 Process for producing ceramic molding ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1988-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080152661-A1 Polyconjugates for In Vivo Delivery of Polynucleotides PHAX, PCBP1, NCL GNAI3 2682/4885GNAO1 3559/4885GNAI1 3359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.